8-K filing — Evofem Biosciences, Inc. (EVFM)
Filed: 2026-07-20 AccNo: 0001493152-26-033910 Size: 9 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Stocks · News reference
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Filed: 2026-07-20 AccNo: 0001493152-26-033910 Size: 9 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Top Wall Street analysts changed outlook on top names. See all changes on analyst ratings page. AVGO receives Outperform rating with $455 PT.
Baird analyst Luke Junk initiates coverage on Hubbell (NYSE:HUBB) with a Outperform rating and announces Price Target of $550.
2023 was a year where investor expectations collided with business reality. While markets recovered from the 2022 selloff, several companies continued to lose billions in market value as growth stories weakened,